QUEBEC CITY, Sept. 11 /CNW Telbec/ - DiagnoCure Inc. (TSX: CUR), a leading developer and provider of innovative high-value cell-based assays and molecular diagnostics for the detection of cancers, today announced its financial results for the third quarter ended July 31, 2006.
